SCHEMBL23674697

SCHEMBL23674697

CN(C)Cc1cnccc1C(=O)O

nearest known ligand 0.49

Predicted protein targets (top 17)

geneUniProtsupporting neighboursconfidence
KDM4C Q9H3R0 13/20 0.49
KDM6B O15054 7/20 0.49
KDM4D Q6B0I6 3/20 0.49
ALDH1A1 P00352 2/20 0.49
KDM4E B2RXH2 2/20 0.49
KDM4A O75164 2/20 0.49
MEN1 O00255 1/20 0.49
MAPT P10636 1/20 0.49
THRB P10828 1/20 0.49
KMT2A Q03164 1/20 0.49
TDP1 Q9NUW8 1/20 0.49
L3MBTL1 Q9Y468 1/20 0.49
SLC6A4 P31645 3/20 0.43
SLC6A2 P23975 2/20 0.43
CHRNB2 P17787 1/20 0.41
CHRNA4 P43681 1/20 0.41
SLC6A3 Q01959 1/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL30100781 0.82 KDM4C (0.56) KDM4CKDM6BKDM4DALDH1A1KDM4E
SCHEMBL115648 0.82 KDM4C (0.56) KDM4CKDM6BKDM4DALDH1A1KDM4E
Hydrochloric Acid SCHEMBL1026385 0.80 KDM4C (0.54) KDM4CKDM6BKDM4DALDH1A1KDM4E
SCHEMBL31132789 0.78 KDM4C (0.55) KDM4CKDM6BKDM4DALDH1A1KDM4E
SCHEMBL31132830 0.78 KDM4C (0.55) KDM4CKDM6BKDM4DALDH1A1KDM4E
SCHEMBL9698166 0.77 KDM4C (0.55) KDM4CKDM6BKDM4DALDH1A1KDM4E
SCHEMBL30100778 0.77 KDM4C (0.55) KDM4CKDM6BKDM4DALDH1A1KDM4E
SCHEMBL30980592 0.77 KDM4C (0.53) KDM4CKDM6BKDM4DALDH1A1KDM4E
SCHEMBL17442725 0.77 KDM4C (0.53) KDM4CKDM6BKDM4DALDH1A1KDM4E
SCHEMBL10467610 0.77 KDM4C (0.53) KDM4CKDM6BKDM4DALDH1A1KDM4E

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20230128402-A1 HETEROCYCLIC COMPOUNDS AND USES THEREOF THE TRUSTEES OF PRINCETON UNIVERSITY 2023-04-27 US disclosed
US-20230128402-A1 HETEROCYCLIC COMPOUNDS AND USES THEREOF THE TRUSTEES OF PRINCETON UNIVERSITY 2023-04-27 US disclosed
US-20230128402-A1 HETEROCYCLIC COMPOUNDS AND USES THEREOF THE TRUSTEES OF PRINCETON UNIVERSITY 2023-04-27 US disclosed
EP-4093400-A1 HETEROCYCLIC COMPOUNDS AND USES THEREOF The Trustees of Princeton University (US) 2022-11-30 EP disclosed
WO-2021151062-A1 HETEROCYCLIC COMPOUNDS AND USES THEREOF THE TRUSTEES OF PRINCETON UNIVERISTY (US) 2021-07-29 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20230128402-A1 HETEROCYCLIC COMPOUNDS AND USES THEREOF PAH, ALDH2, IDH2 KDM4C 1712/4885KDM6B 1330/4885KDM4D 2730/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.